Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 5250-5256, October 1, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fonagy, A.
Right arrow Articles by Freeman, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fonagy, A.
Right arrow Articles by Freeman, J. W.

Antisense-mediated Specific Inhibition of P120 Protein Expression Prevents G1- to S-Phase Transition1

Anna Fonagy, Carol Swiderski, Melissa Dunn and James W. Freeman2

Department of Surgery, Division of General Surgery, and Department of Microbiology and Immunology, Lucille Markey Cancer Center, University of Kentucky Medical Center, Lexington, Kentucky 40536

A pentadecadeoxyribonucleotide (5'-AAAGCCCCCCACCAC), complementary to a splice junction site of mRNA for human proliferation-associated nucleolar protein P120, inhibited expression of the P120 gene and the mitogen-induced proliferation of human lymphocytes. The inhibition of P120 gene expression and proliferation was concentration dependent and reached 90% at 200 µM, as measured by [3H]thymidine uptake and by densitometric scanning of Northern (mRNA) and Western (protein) blots of P120. Inhibition was not observed in cells treated with the correspondent nonsense oligomer. P120 antisense oligomer treatment prevented S-phase entry of mitogen-stimulated lymphocytes, as determined by flow cytometric analysis, but did not block G0-G1 transition assessed by morphological blast transformation and induction of [3H]uridine incorporation. Results of this study suggest that P120 expression may be required for the upregulation of nucleolar function necessary for cell proliferation.

1 This work was supported by grant CA49633 from the USPHS-National Cancer Institute.

2 To whom requests for reprints should be addressed, at Combs Research Facility, Rm. 313, University of Kentucky Medical Center, 800 Rose Street, Lexington, KY 40536-0093.

Received 3/12/92. Accepted 7/23/92.




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
D. G. Pestov, Z. Strezoska, and L. F. Lau
Evidence of p53-Dependent Cross-Talk between Ribosome Biogenesis and the Cell Cycle: Effects of Nucleolar Protein Bop1 on G1/S Transition
Mol. Cell. Biol., July 1, 2001; 21(13): 4246 - 4255.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. C. Chou and B. Y. M. Yung
Increased Stability of Nucleophosmin/B23 in Anti-Apoptotic Effect of Ras during Serum Deprivation
Mol. Pharmacol., January 1, 2001; 59(1): 38 - 45.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. Amann, V. J. Kidd, and J. M. Lahti
Characterization of Putative Human Homologues of the Yeast Chromosome Transmission Fidelity Gene, CHL1
J. Biol. Chem., February 7, 1997; 272(6): 3823 - 3832.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.